Analytical Testing

CELL CULTURE MARKET – 3D Cell Cultures: Next Generation & New Challenges

Kevin James and Robert G. Hunter of BCC Research say significant growth within the biopharmaceuticals industry is spurring unprecedented innovation in and demand for cell culture products for the purposes of drug discovery and safety testing. While 2D cell cultures have been in laboratory use since the 1950s, the market for 3D cultures has witnessed spectacular growth throughout the past decade.

EXCLUSIVE ONLINE CONTENT

7/10/2018

Endocyte & ITM Announce Long-Term Supply Agreement

Endocyte, Inc. and ITM Isotopen Technologien München AG recently announced that ITM´s subsidiary, Isotope Technologies Garching GmbH (ITG), and Endocyte have signed a long-term global…

7/8/2018

Pfenex Receives Milestone From Merck

Pfenex Inc. recently announced the receipt of a milestone payment from Merck associated with the initiation of the first Phase 3 clinical study of (V114), an investigational polyvalent conjugate vaccine for the prevention of pneumococcal disease. 

7/8/2018

Immatics Enters Strategic Partnership With Genmab

Immatics Biotechnologies GmbH recently announced it has entered into a research collaboration and license agreement with Genmab A/S to develop next-generation, T-cell engaging bispecific immunotherapies targeting multiple cancer indications.

7/8/2018

Gerresheimer Acquires Sensile Medical

With the acquisition of Sensile Medical AG, Switzerland  under a recent share purchase agreement, Gerresheimer is extending its business model in the direction of an Original Equipment Manufacturer (OEM) for drug delivery platforms with digital and electronic capabilities for pharmaceutical and biopharmaceutical customers.